CIBA CONSUMER PHARMACEUTICALS REACHES AGREEMENT WITH FISONS PLC
ARDSLEY, N.Y., Nov. 25 ~PRNewswire~ -- Ciba Consumer Pharmaceuticals, a division of Ciba-Geigy Corporation, has agreed with Fisons plc, to purchase Fisons' North American consumer healthcare business. The purchase is expected to be completed in early 1993, and is subject to any necessary United States and Canadian regulatory approvals. The agreement includes the purchase of certain product lines, accounts receivable and inventories, but no manufacturing facilities of Fisons. The product portfolio includes Desenex(R) and Cruex(R) antifungal medications, Allerest(R) line of allergy relief products, Myoflex(R) topical analgesic, and several other skin care products. Ciba Consumer Pharmaceuticals markets popular over-the-counter medications such as Doan's(R) back-ache remedy, Dulcolax(R) and Fiberol(R) laxatives, Acutrim(R) appetite suppressant, Sunkist(R) and Slow-Se(R) vitamins, and the prescription transdermal motion sickness patch, Transderm Scop(R).
Ciba Consumer Pharmaceuticals is based in Woodbridge, N.J.; Fisons is based in the United Kingdom.
Ciba Consumer Pharmaceuticals is a subsidiary of Ciba-Geigy Corporation, a leading developer and manufacturer of healthcare, agricultural and industrial products. -0- 11~25~92 ~CONTACT: Lisa Robinson of Ciba, 914-479-4050 or 914-736-7123~
CO: Ciba Consumer Pharmaceuticals; Fisons plc ST: New York IN: MTC SU: TNM
TM -- NY070 -- 1719 11~25~92 23:20 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 25, 1992|
|Previous Article:||GOTTSCHALKS ANNOUNCES CHAIRMAN TARGET OF INVESTIGATION|
|Next Article:||MONEY SMALL INVESTOR INDEX: INVESTORS PUMP CASH INTO REAL ESTATE FUNDS|